Calithera Biosciences, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CALA research report →
Companywww.calithera.com
Calithera Biosciences, Inc. , a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company offers INCB001158, an orally bioavailable arginase inhibitor of arginase that is in Phase 1/2 clinical trial for the treatment of hematology and oncology.
- CEO
- Stephanie Wong
- IPO
- 2014
- Employees
- 8
- HQ
- South San Francisco, CA, US
Price Chart
Valuation
- Market Cap
- $2.44K
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.62
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -131.13%
- ROIC
- -184.41%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-18,866,000 · 83.61%
- EPS
- $-7.94 · 74.52%
- Op Income
- $-42,074,000
- FCF YoY
- 34.17%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.07
- Avg Volume
- 392
Get TickerSpark's AI analysis on CALA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 17, 23 | TAKEDA PHARMACEUTICAL CO LTD | other | 1,000,000 |
| Jan 27, 23 | PAKIANATHAN DEEPIKA | sell | 1,172 |
| Jan 23, 23 | Sjogren Eric | other | 279 |
| Jan 23, 23 | Kuriakose Emil | other | 79 |
| Jan 23, 23 | Molineaux Susan | other | 526 |
| Jan 23, 23 | Wong Stephanie | other | 317 |
| Jan 23, 23 | Molineaux Christopher | other | 217 |
| Jul 1, 22 | Takeda Ventures, Inc. | other | 1,000,000 |
| Jul 1, 22 | TAKEDA PHARMACEUTICAL CO LTD | other | 1,000,000 |
| Jul 1, 22 | Takeda Ventures, Inc. | other | 1,000,000 |
Our CALA Coverage
We haven't published any research on CALA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CALA Report →